These changes lead to frequent inflammation and are not affected by drugs targeting the altered mucus production. Despite new medication, cystic fibrosis often leads to permanent lung damage.

Through this acquisition, Inogen acquired Simeox from Physio-Assist which is a technology-enabled airway clearance and mucus management device for treatment of cystic fibrosis. To read more about ...

These changes lead to frequent inflammation and are not affected by drugs targeting the altered mucus production. Cystic fibrosis is caused by hereditary genetic mutations that impair or halt the ...

Airway clearance devices facilitate chest physical therapy through high-frequency vibrations, helping to loosen and thin the thick, sticky mucus characteristic of cystic fibrosis. According to ...

These changes lead to frequent inflammation and are not affected by drugs targeting the altered mucus production. Cystic fibrosis is caused by hereditary genetic mutations that impair or halt the ...

These changes lead to frequent inflammation and are not affected by drugs targeting the altered mucus production. Cystic fibrosis is caused by hereditary genetic mutations that impair or halt the ...

In people with CF, mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene cause the CFTR protein to become dysfunctional. When the protein is not working correctly, it’s ...

These changes lead to frequent inflammation and are not affected by drugs targeting the altered mucus production. Cystic fibrosis is caused by hereditary genetic mutations that impair or halt the ...